Hints and tips:
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
...The verdict includes $1bn in punitive damages against J&J and DePuy, a subsidiary, as well as $30m in actual damages for the plaintiffs, according to Mark Lanier, the lead attorney for the plaintiffs....
...The company took unspecified litigation charges, against a backdrop of continuing legal actions including compensation demands from users of its DePuy ASR artificial hip....
...The company is also facing an onslaught of lawsuits related to faulty hip implants produced by its DePuy unit....
...DePuy, the division of J&J that Synthes would potentially join, made revenues of $5.6bn but supposedly lower profitability....
...DePuy, a division of Johnson & Johnson, the largest US healthcare group, on Wednesday crystallised the value of that initiative by agreeing one of the biggest ever takeovers in the medical devices sector...
...The UK’s Medicines and Healthcare Products Regulatory Agency, for example, was the first to identify problems with DePuy’s ASR artificial metal hips, triggering recalls in 2009 and 2010....
...This was mainly due to a $922m charge related to the ASR hip recall from its DePuy subsidiary....
...J&J was hit by $271m of charges related to its DePuy ASR, a hip replacement which had to be recalled....
...J&J booked $271m of charges related to its DePuy ASR, a hip replacement which had to be recalled....
...Last year J&J took after-tax charges of $922m due to lawsuits related to its DePuy ASR replacement hip, which was recalled, and other product liabilities and litigation....
...Results from DePuy, Johnson & Johnson’s orthopaedics division, and Stryker, both highlighted slowing demand for replacement knees, an important product segment for S&N....
...The company took after-tax charges of $922m during the year to cover the impact of litigation around its DePuy ASR replacement hip, which was recalled, and other product liabilities and litigation....
...Mr Dougall, a former vice-president of DePuy International, a Leeds-based subsidiary of Johnson & Johnson of the US, was one of the administrators of a conspiracy to pay £4.5m of bribes to Greek healthcare...
...Once combined with J&J’s DePuy business it would have a 35 per cent global market share in hips and knees. S&N is also big in arthroscopy — around a third of the global market according to Merrill....
...DePuy said it was taking the matter very seriously and was co-operating with the appropriate authorities....
...Smith & Nephew dropped 3.2 per cent to 532p after Johnson & Johnson, owner of DePuy Orthopaedics, posted weaker-than-expected quarterly sales....
...In the case, Zimmer and four other companies – Depuy, Biomet, Stryker of the US and Smith & Nephew of the UK – were accused of paying large sums of money to surgeons as well as giving them trips and expensive...
...Cummins has invested heavily in Holset, and the West Yorkshire operations of companies ranging from Johnson & Johnson’s DePuy, (medical technology) to Sulzer Pumps prove that many of the most successful...
...And it is a knee made by J&J’s DePuy, of course....
...Growth in J&J’s medical device business, including its Depuy hip and knee replacement and implant unit, offset the group’s lacklustre pharma business results....
...DePuy Orthopaedics, Inc., a $3bn company and the oldest orthopaedics manufacturer in the US, designs and manufactures devices and supplies - including hip, knee, ankle, shoulder, wrist, elbow, and finger...
International Edition